480 related articles for article (PubMed ID: 17251552)
1. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells.
Chareonsirisuthigul T; Kalayanarooj S; Ubol S
J Gen Virol; 2007 Feb; 88(Pt 2):365-375. PubMed ID: 17251552
[TBL] [Abstract][Full Text] [Related]
2. Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection.
Callaway JB; Smith SA; McKinnon KP; de Silva AM; Crowe JE; Ting JP
J Biol Chem; 2015 Jul; 290(28):17306-20. PubMed ID: 26032420
[TBL] [Abstract][Full Text] [Related]
3. Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.
Wang M; Yang F; Huang D; Huang Y; Zhang X; Wang C; Zhang S; Zhang R
Front Cell Infect Microbiol; 2017; 7():157. PubMed ID: 28536674
[TBL] [Abstract][Full Text] [Related]
4. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.
Boonnak K; Dambach KM; Donofrio GC; Tassaneetrithep B; Marovich MA
J Virol; 2011 Feb; 85(4):1671-83. PubMed ID: 21123382
[TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy.
Huang X; Yue Y; Li D; Zhao Y; Qiu L; Chen J; Pan Y; Xi J; Wang X; Sun Q; Li Q
Sci Rep; 2016 Feb; 6():22303. PubMed ID: 26923481
[TBL] [Abstract][Full Text] [Related]
6. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.
Boonnak K; Slike BM; Burgess TH; Mason RM; Wu SJ; Sun P; Porter K; Rudiman IF; Yuwono D; Puthavathana P; Marovich MA
J Virol; 2008 Apr; 82(8):3939-51. PubMed ID: 18272578
[TBL] [Abstract][Full Text] [Related]
7. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability.
Puerta-Guardo H; Raya-Sandino A; González-Mariscal L; Rosales VH; Ayala-Dávila J; Chávez-Mungía B; Martínez-Fong D; Medina F; Ludert JE; del Angel RM
J Virol; 2013 Jul; 87(13):7486-501. PubMed ID: 23616663
[TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes.
Tsai TT; Chuang YJ; Lin YS; Chang CP; Wan SW; Lin SH; Chen CL; Lin CF
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3320. PubMed ID: 25412261
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():597. PubMed ID: 29740424
[TBL] [Abstract][Full Text] [Related]
10. NK Cells Activated through Antibody-Dependent Cell Cytotoxicity and Armed with Degranulation/IFN-γ Production Suppress Antibody-dependent Enhancement of Dengue Viral Infection.
Sun P; Williams M; Nagabhushana N; Jani V; Defang G; Morrison BJ
Sci Rep; 2019 Feb; 9(1):1109. PubMed ID: 30710094
[TBL] [Abstract][Full Text] [Related]
11. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.
Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S
Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564
[TBL] [Abstract][Full Text] [Related]
12. Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
Chan CYY; Low JZH; Gan ES; Ong EZ; Zhang SL; Tan HC; Chai X; Ghosh S; Ooi EE; Chan KR
mSphere; 2019 Sep; 4(5):. PubMed ID: 31533998
[TBL] [Abstract][Full Text] [Related]
13. Protein Disulfide Isomerase Inhibitor Suppresses Viral Replication and Production during Antibody-Dependent Enhancement of Dengue Virus Infection in Human Monocytic Cells.
Rawarak N; Suttitheptumrong A; Reamtong O; Boonnak K; Pattanakitsakul SN
Viruses; 2019 Feb; 11(2):. PubMed ID: 30781856
[TBL] [Abstract][Full Text] [Related]
14. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
[TBL] [Abstract][Full Text] [Related]
15. The Role of Autophagy-Mediated Dengue Virus Antibody-Dependent Enhancement Infection of THP-1 Cells.
Jiang L; Sun Q
Intervirology; 2020; 63(1-6):57-65. PubMed ID: 33202415
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative.
Ayala-Nuñez NV; Jarupathirun P; Kaptein SJ; Neyts J; Smit JM
Antiviral Res; 2013 Oct; 100(1):238-45. PubMed ID: 23994499
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner.
Fagundes CT; Costa VV; Cisalpino D; Amaral FA; Souza PR; Souza RS; Ryffel B; Vieira LQ; Silva TA; Atrasheuskaya A; Ignatyev G; Sousa LP; Souza DG; Teixeira MM
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1449. PubMed ID: 22206036
[TBL] [Abstract][Full Text] [Related]
18. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
[TBL] [Abstract][Full Text] [Related]
19. Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse.
Modhiran N; Kalayanarooj S; Ubol S
PLoS Negl Trop Dis; 2010 Dec; 4(12):e924. PubMed ID: 21200427
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide acts synergistically with the dengue virus to induce monocyte production of platelet activating factor and other inflammatory mediators.
Kamaladasa A; Gomes L; Jeewandara C; Shyamali NL; Ogg GS; Malavige GN
Antiviral Res; 2016 Sep; 133():183-90. PubMed ID: 27476044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
